Abstract
The focus of the present study was the monitoring of ambrisentan (AMB) in vitro biotransformation by two fungal cultures: Aspegillus niger ATCC 9029 and Penicillium mineoluteum URM 6889. This drug is a selective endothelin Type A, receptor antagonist, used for pulmonary arterial hypertension. In vitro metabolism study was carried out by incubating AMB with fungus and culture medium under controlled conditions for further analysis of metabolites formed through an alternative method. After incubation for 240 hours with A. niger , drug was metabolized into two substances: one is known (M2) with 3.75 min retention time and another unknown (M3) at 4.37 min retention time in high performance liquid chromatography–diode array detector method (HPLC‐DAD). Structures were suggested by using ultra high performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry (UHPLC‐QTOF/MS) method. When drug was submitted to biotransformation with P. mineoluteum , no different signals than those formed in the controls were observed, demonstrating it is not adequate to the purpose. The findings indicate that fungi A. niger could be used to generate mammalian metabolites of AMB on a small scale and can also be used as reference standard for identification and analytical tests of mammalian metabolites of this drug.
Funding Information
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)

This publication has 31 references indexed in Scilit: